However, the CD4+:CD8+ TIL ratio was significantly lower in the group with the recurrence, or more specifically, this group had a greater number of CD8+ TILs, thus indicating that CD8+ TILs could be associated with bladder cancer recurrence. The gene discussed is CD4; the disease is urinary bladder carcinoma.